Apex AI has developed a cutting-edge AI-driven early detection system for stomach and colorectal cancer, leveraging over 1 million endoscopic imaging datasets to assist in the diagnosis of precancerous lesions, early-stage cancer, and advanced cancer.
Divides the gastrointestinal tract into 14 anatomical regions for precise localization of abnormalities.
Detects key gastrointestinal conditions, including:
Precancerous lesions: Atrophic gastritis, intestinal metaplasia.
Inflammatory conditions: Gastric ulcers, erosions, colitis.
Apex AI's system offers real-time image analysis, automated abnormality detection, and longitudinal disease tracking.
Patient Search & Data Integration
Connects with electronic medical records (EMR) for streamlined patient data access.
Allows historical comparisons of previous scans for tracking disease progression.
A retrospective clinical study comparing AI-assisted diagnosis with a panel of experienced doctors demonstrated superior accuracy in all key performance metrics.
AI outperformed human doctors in accuracy, sensitivity, specificity, and precision.
The AI model significantly reduces false negatives, ensuring high-risk lesions are detected early.
AI-powered endoscopic analysis can improve diagnostic reliability and reduce misdiagnosis rates, leading to better patient outcomes.
Early-stage stomach and colorectal cancers are often misdiagnosed or missed entirely due to subtle visual characteristics.
AI enhances diagnostic confidence by improving detection accuracy, reducing human error, and supporting physicians in real-time.
By adopting AI-assisted endoscopy, hospitals and clinics can drastically improve cancer survival rates worldwide.
Apex AI is at the forefront of this transformation, providing a next-generation AI diagnostic platform that will shape the future of gastrointestinal cancer detection.
Early and advanced cancers: Stomach and colorectal cancer.
Seamlessly integrates with hospital imaging and endoscopic systems to enhance real-time clinical decision-making.
AI continuously analyzes real-time endoscopic footage, marking potential abnormalities.
Provides a comparative review of previous images to detect disease progression over time.
Time-Based & Region-Based Disease Tracking
Allows doctors to monitor lesion evolution in specific locations within the gastrointestinal tract.
Enhances precision in monitoring high-risk patients over multiple screenings.
High-Resolution Image Processing & Zoom Analysis
Enables doctors to zoom into detected lesions for a more detailed pathological assessment.
Reduces false positives by refining image interpretation.
0.98
Doctor Panel (4 Physicians Average)
67%
69%
55%
70%
0.67
Cancer Risk Prediction
Accuracy
Sensitivity (Recall)
Specificity
Precision
F1 Score
AI (Stomach Cancer)
95%
94%
99%
95%
0.94
AI (Colorectal Cancer)
99%
98%
99%
98%